These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
665 related articles for article (PubMed ID: 28228078)
1. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment. Gungor S; Rezigue M Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078 [TBL] [Abstract][Full Text] [Related]
2. Exploring the potential of nanocarriers in antipsoriatic therapeutics. Shaif M; Kushwaha P; Usmani S; Pandey S J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857 [TBL] [Abstract][Full Text] [Related]
3. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967 [TBL] [Abstract][Full Text] [Related]
5. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool. Thakur K; Sharma G; Singh B; Katare OP Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036 [TBL] [Abstract][Full Text] [Related]
6. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery. Kahraman E; Güngör S; Özsoy Y Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106 [TBL] [Abstract][Full Text] [Related]
7. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Doppalapudi S; Jain A; Chopra DK; Khan W Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066 [TBL] [Abstract][Full Text] [Related]
8. Novel Topical Nanocarriers for Treatment of Psoriasis: An Overview. Dadwal A; Mishra N; Narang RK Curr Pharm Des; 2018; 24(33):3934-3950. PubMed ID: 30387390 [TBL] [Abstract][Full Text] [Related]
9. Polymeric micelles as cutaneous drug delivery system in normal skin and dermatological disorders. Makhmalzade BS; Chavoshy F J Adv Pharm Technol Res; 2018; 9(1):2-8. PubMed ID: 29441317 [TBL] [Abstract][Full Text] [Related]
10. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Pradhan M; Alexander A; Singh MR; Singh D; Saraf S; Saraf S; Ajazuddin Biomed Pharmacother; 2018 Nov; 107():447-463. PubMed ID: 30103117 [TBL] [Abstract][Full Text] [Related]
11. Transdermal Drug Delivery: Opportunities and Challenges for Controlled Delivery of Therapeutic Agents Using Nanocarriers. Kurmi BD; Tekchandani P; Paliwal R; Paliwal SR Curr Drug Metab; 2017; 18(5):481-495. PubMed ID: 28228076 [TBL] [Abstract][Full Text] [Related]
12. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Raza K; Singh B; Lohan S; Sharma G; Negi P; Yachha Y; Katare OP Int J Pharm; 2013 Nov; 456(1):65-72. PubMed ID: 23973754 [TBL] [Abstract][Full Text] [Related]
13. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. Pradhan M; Singh D; Singh MR J Control Release; 2013 Sep; 170(3):380-95. PubMed ID: 23770117 [TBL] [Abstract][Full Text] [Related]
14. Ethosomes-mediated tryptanthrin delivery as efficient anti-psoriatic nanotherapy by enhancing topical drug absorption and lipid homeostasis. Wang P; Hong S; Cao C; Guo S; Wang C; Chen X; Wang X; Song P; Li N; Xu R J Nanobiotechnology; 2024 Sep; 22(1):584. PubMed ID: 39334378 [TBL] [Abstract][Full Text] [Related]
15. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin. Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553 [No Abstract] [Full Text] [Related]
16. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis. Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809 [TBL] [Abstract][Full Text] [Related]
17. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS). Sala M; Elaissari A; Fessi H J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248 [TBL] [Abstract][Full Text] [Related]
18. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. Sala M; Diab R; Elaissari A; Fessi H Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097 [TBL] [Abstract][Full Text] [Related]
19. Liposome Based Drug Delivery for the Management of Psoriasis - A Comprehensive Review. Bahadur S; Sharma M Curr Pharm Biotechnol; 2023; 24(11):1383-1396. PubMed ID: 36518042 [TBL] [Abstract][Full Text] [Related]
20. New Insights in Psoriasis Management using Herbal Drug Nanocarriers. Salgaonkar SP; Purewal JS; Doshi GM; Fernandes T; Gharat S; Sawarkar SP Curr Pharm Des; 2024; 30(32):2550-2561. PubMed ID: 39051579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]